GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » ALR Technologies SG Ltd (OTCPK:ALRTF) » Definitions » EPS (Diluted)

ALRTF (ALR Technologies SG) EPS (Diluted) : $-0.01 (TTM As of Jun. 2024)


View and export this data going back to 1998. Start your Free Trial

What is ALR Technologies SG EPS (Diluted)?

ALR Technologies SG's Earnings per Share (Diluted) for the six months ended in Jun. 2024 was $-0.01. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 was $-0.01.

ALR Technologies SG's EPS (Basic) for the six months ended in Jun. 2024 was $-0.01. Its EPS (Basic) for the trailing twelve months (TTM) ended in Jun. 2024 was $-0.01.

ALR Technologies SG's EPS without NRI for the six months ended in Jun. 2024 was $-0.01. Its EPS without NRI for the trailing twelve months (TTM) ended in Jun. 2024 was $-0.01.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.


ALR Technologies SG EPS (Diluted) Historical Data

The historical data trend for ALR Technologies SG's EPS (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ALR Technologies SG EPS (Diluted) Chart

ALR Technologies SG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EPS (Diluted)
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.04 -0.02 -0.02 -0.02 -0.01

ALR Technologies SG Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
EPS (Diluted) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.01 -0.01 -0.01 - -0.01

Competitive Comparison of ALR Technologies SG's EPS (Diluted)

For the Medical Devices subindustry, ALR Technologies SG's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ALR Technologies SG's PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, ALR Technologies SG's PE Ratio distribution charts can be found below:

* The bar in red indicates where ALR Technologies SG's PE Ratio falls into.


;
;

ALR Technologies SG EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

ALR Technologies SG's Diluted EPS for the fiscal year that ended in Dec. 2023 is calculated as

Diluted EPS (A: Dec. 2023 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-7.475-0)/581.016
=-0.01

ALR Technologies SG's Diluted EPS for the quarter that ended in Jun. 2024 is calculated as

Diluted EPS (Q: Jun. 2024 )=(Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-6.028-0)/598.373
=-0.01

EPS (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-0.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


ALR Technologies SG  (OTCPK:ALRTF) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


ALR Technologies SG EPS (Diluted) Related Terms

Thank you for viewing the detailed overview of ALR Technologies SG's EPS (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


ALR Technologies SG Business Description

Traded in Other Exchanges
N/A
Address
7400 Beaufont Springs Drive, Suite 300, Richmond, VA, USA, 23225
ALR Technologies SG Ltd is a medical device company, which focuses on commercializing its Health-e-Connect System. It has developed a compliance monitoring system that will allow healthcare professionals to remotely monitor patient health conditions and provide patient health management. The company's Health-e-Connect Remote Diabetes Management Program is remote monitoring and care facilitation program that allows patients to upload their blood glucose data from their glucometers. Its geographical segments are the United States, which derives maximum revenue, Singapore, and Others.
Executives
Sidney Chan director, officer: CEO 7400 BEAUFONT SPRINGS DRIVE, SUITE 300, SUITE 300, RICHMOND VA 23225
Ronald Cheng director 255 SPRINGFIELD ROAD, OTTAWA A6 K1M 0K8
Peter H Stafford director 1-405 81ST STREET, OSOYOOS A1 V0H 1V2
William S Smith director, officer: Chief Commercial Officer 46 CHESTNUT HILL ROAD, WILTON CT 06897
Kenneth Robulak director 521 MANDALAY AVENUE, APT. 302, CLEARWATER FL 33767
Alfonso Salas director 2106 WEST 33RD AVENUE, VANCOUVER A1 V6M 1B9
Lawrence A Weinstein director, officer: President 13436 BLUE HEON LOOP, CHESTERFIELD VA 23838
Jaroslav V Tichy officer: Vice-President - Technologies 114M REYNOLDA VILLAGE, WINSTON-SALEM NC 27106
Stanley Cruitt director, 10 percent owner, officer: President 114M REYNOLDA VILLAGE, WINSTON-SALEM NC 27106